Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oxid Med Cell Longev ; 2016: 2136902, 2016.
Article in English | MEDLINE | ID: mdl-27579149

ABSTRACT

Purpose. The aim of this study was to assess the effect of melatonin in the proliferation of neural progenitors, melatonin concentration, and antiapoptotic proteins in the hippocampus of adult mice exposed to 96 h REM sleep deprivation (REMSD) prophylactic administration of melatonin for 14 days. Material and Methods. Five groups of Balb/C mice were used: (1) control, (2) REMSD, (3) melatonin (10 mg/kg) plus REMSD, (4) melatonin and intraperitoneal luzindole (once a day at 5 mg/kg) plus REMSD, and (5) luzindole plus REMSD. To measure melatonin content in hippocampal tissue we used HPLC. Bcl-2 and Bcl-xL proteins were measured by Western Blot and neurogenesis was determined by injecting 5-bromo-2-deoxyuridine (BrdU) and BrdU/nestin expressing cells in the subgranular zone of the dentate gyrus were quantified by epifluorescence. Results. The melatonin-treated REMSD group showed an increased neural precursor in 44% with respect to the REMSD group and in 28% when contrasted with the control group (P < 0.021). The melatonin-treated REMSD group also showed the highest expression of Bcl-2 and Bcl-xL as compared to the rest of the groups. Conclusion. The exogenous administration of melatonin restores the tissue levels of sleep-deprived group and appears to be an efficient neuroprotective agent against the deleterious effects of REMSD.


Subject(s)
Melatonin/administration & dosage , Neural Stem Cells/drug effects , Neurogenesis/drug effects , Sleep Deprivation/pathology , Sleep, REM/drug effects , Administration, Oral , Animals , Cell Proliferation/drug effects , Central Nervous System Depressants/administration & dosage , Central Nervous System Depressants/pharmacokinetics , Hippocampus/metabolism , Male , Melatonin/pharmacokinetics , Mice , Mice, Inbred BALB C , Neural Stem Cells/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Random Allocation , Sleep Deprivation/drug therapy , Sleep Deprivation/metabolism , bcl-X Protein/metabolism
2.
Noise Health ; 17(77): 216-26, 2015.
Article in English | MEDLINE | ID: mdl-26168952

ABSTRACT

In this experiment, we evaluated the long-term effects of noise by assessing both astrocyte changes in medial prefrontal cortex (mPFC) and mPFC-related alternation/discrimination tasks. Twenty-one-day-old male rats were exposed during a period of 15 days to a standardized rats' audiogram-fitted adaptation of a human noisy environment. We measured serum corticosterone (CORT) levels at the end of the exposure and periodically registered body weight gain. In order to evaluate the long-term effects of this exposure, we assessed the rats' performance on the T-maze apparatus 3 months later. Astrocyte numbers and proliferative changes in mPFC were also evaluated at this stage. We found that environmental noise (EN) exposure significantly increased serum CORT levels and negatively affected the body weight gain curve. Accordingly, enduring effects of noise were demonstrated on mPFC. The ability to solve alternation/discrimination tasks was reduced, as well as the number of astroglial cells. We also found reduced cytogenesis among the mPFC areas evaluated. Our results support the idea that early exposure to environmental stressors may have long-lasting consequences affecting complex cognitive processes. These results also suggest that glial changes may become an important element behind the cognitive and morphological alterations accompanying the PFC changes seen in some stress-related pathologies.


Subject(s)
Astrocytes/metabolism , Maze Learning , Memory, Short-Term/physiology , Noise , Prefrontal Cortex/cytology , Prefrontal Cortex/metabolism , Animals , Astrocytes/cytology , Cell Count , Immunohistochemistry , Male , Rats
3.
Neurosci Res ; 47(2): 219-24, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14512146

ABSTRACT

Oxidative stress increases delayed neuronal death in the brain following ischemia. As a consequence, many attempts to reduce the damage resulting from cerebral ischemia under more highly oxidized conditions have focused on treatments aimed at maintaining the redox equilibrium of the local environment. This study demonstrates the synergistic effects of combining treatments with alpha-lipoic acid (LA) and vitamin E (VE) as an efficient measure to reduce the damage caused by cerebral ischemia. Two oral therapeutic protocols were examined: intensive treatment (100 mg/kg LA and 140 mg/kg VE for 7 days after ischemia) and prophylactic treatment (20 mg/kg LA and 50 mg/kg VE from 30 days before infarction up to the day of sacrifice). The prophylactic treatment reduced serum lipid peroxidation, and diminished brain infarct volume by approximately 50%. Furthermore, prophylactically treated rats showed a reduction in post-ischemia neurological scores. No significant differences were found in the intensively treated group. Our data indicate that pre-ischemia administration of the LA-VE antioxidant mixture reduced the volume of brain damaged and the functional consequences of embolic infarction. These findings suggest that prophylaxis with an LA-VE mixture may be valuable in reducing cerebral damage levels in patients with a high risk of stroke.


Subject(s)
Cerebral Infarction/prevention & control , Intracranial Embolism/prevention & control , Lipid Peroxidation/drug effects , Thioctic Acid/therapeutic use , Vitamin E/therapeutic use , Animals , Cerebral Infarction/pathology , Drug Therapy, Combination , Intracranial Embolism/pathology , Lipid Peroxidation/physiology , Male , Nervous System Diseases/pathology , Nervous System Diseases/prevention & control , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Rats , Rats, Wistar , Thioctic Acid/pharmacology , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...